Ellis Pharmaceuticals

This article, Ellis Pharmaceuticals, was written by RelentlessRecusant. Please do not edit this fiction without the writer's permission.

Ellis Pharmaceuticals is a major pharmaceutical corporation headquartered on Noveria with a galactically-renowned drug discovery program that specializes in rational and targeted drug discovery projects to provide small-molecule modulators of pathologically-associated cellular signaling pathways to cure human disease.

Characterized small molecules

• EP-107002 ("Psychonikin", "EZM-1"): Neuronal genomic mutagen, functional connotation: first-iteration element zero mimetic
• EP-107560 ("Neuronikin", "EZM-3"): Neuronal genomic mutagen, functional connotation: third-iteration element zero mimetic^†
• EP-189430 ("Cyclogenol"): CDKN1B inhibitor, functional connotation: cell cycle^†
• EP-215016 ("Multigenol"): GSK3β inhibitor, functional connotation: self-renewal^†
• EP-274583 ("Metabotropin"): IGFR1 agonist, functional connotation: metabolism^†
• EP-357470 ("Fibrocidine"): TGFβRI agonist, functional connotation: exocytosis^†
• EP-509475 ("Osteomorphin"): ACVR1 agonist, functional connotation: exocytosis^†
• EP-532916 ("Myopentin"): NOTCH1 agonist, functional connotation: self-renewal^†
• EP-586037 ("Neuroplastin"): IKKβ inhibitor, functional connotation: long-term potentiation^†
• EP-684188 ("Glucothene"): GCK agonist, functional connotation: metabolism^†
• EP-740836 ("Memorscidin"): ERK agonist, functional connotation: long-term potentiation^†
• EP-948517 ("Endurcyclin"): AMPK agonist, functional connotation: metabolism^†

^† = Orally-bioavailable

Behind the Scenes

• The Ellis Pharmaceuticals article was inspired by Acumen Science Laboratories, a substantiative article written by author RelentlessRecusant written about a fictitious pharmaceutical company set in the Halo universe.